Genomic aspects of sporadic neurodegenerative diseases

Biochemical and Biophysical Research Communications

Volumn 452, Issue 2, 2014, Pages 221-225

  Mitsui, Jun ^a   Tsuji, Shoji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Common disease multiple rare variants hypothesis; Genome wide association studies; Next generation sequencing technologies; Sporadic neurodegenerative disease

Indexed keywords

ALZHEIMER DISEASE; AUTONOMIC DYSFUNCTION; AUTOSOMAL DOMINANT INHERITANCE; CEREBELLAR ATAXIA; CLINICAL FEATURE; COGNITIVE DEFECT; CONCEPTUAL FRAMEWORK; DEGENERATIVE DISEASE; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENETIC ASSOCIATION; GENETICS; GENOMICS; PARKINSON DISEASE; PARKINSONISM; REVIEW; SHY DRAGER SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; SPORADIC NEURODEGENERATIVE DISEASE; STRIATONIGRAL DEGENERATION; COMMON DISEASE-MULTIPLE RARE VARIANTS HYPOTHESIS; GENOME-WIDE ASSOCIATION STUDIES; HUMAN; NEXT-GENERATION SEQUENCING TECHNOLOGIES;

COMMON DISEASE-MULTIPLE RARE VARIANTS HYPOTHESIS; GENOME-WIDE ASSOCIATION STUDIES; NEXT-GENERATION SEQUENCING TECHNOLOGIES; SPORADIC NEURODEGENERATIVE DISEASE;

ALZHEIMER DISEASE; GENOMICS; HUMANS; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE;

EID: 84908611463     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.098     Document Type: Review

References (94)

1. A.H. Peden, and J.W. Ironside Molecular pathology in neurodegenerative diseases Curr. Drug Targets 13 2012 1548 1559
2. S. Tsuji The neurogenomics view of neurological diseases JAMA Neurol. 70 2013 689 694
3. E.L. Thacker, and A. Ascherio Familial aggregation of Parkinson's disease: a meta-analysis Mov. Disord. 23 2008 1174 1183
4. F. Fang, F. Kamel, and P. Lichtenstein Familial aggregation of amyotrophic lateral sclerosis Ann. Neurol. 66 2009 94 99
5. M. Martinez, D. Campion, and A. Brice Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease Arch. Neurol. 55 1998 810 816
6. S. Tsuji Genetics of neurodegenerative diseases: insights from high-throughput resequencing Hum. Mol. Genet. 19 2010 R65 R70
7. F.S. Collins Positional cloning: let's not call it reverse anymore Nat. Genet. 1 1992 3 6
8. V.A. McKusick Mendelian inheritance in man and its online version, OMIM Am. J. Hum. Genet. 80 2007 588 604
9. S.B. Ng, A.W. Bigham, and K.J. Buckingham Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome Nat. Genet. 42 2010 790 793
10. S.B. Ng, K.J. Buckingham, and C. Lee Exome sequencing identifies the cause of a mendelian disorder Nat. Genet. 42 2010 30 35
11. K. Bilgüvar, A.K. Oztürk, and A. Louvi Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations Nature 467 2010 207 210
12. E.A. Otto, T.W. Hurd, and R. Airik Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy Nat. Genet. 42 2010 840 850
13. T.B. Haack, K. Danhauser, and B. Haberberger Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency Nat. Genet. 42 2010 1131 1134
14. C. Gilissen, H.H. Arts, and A. Hoischen Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome Am. J. Hum. Genet. 87 2010 418 423
15. S.B. Ng, E.H. Turner, and P.D. Robertson Targeted capture and massively parallel sequencing of 12 human exomes Nature 461 2009 272 276
16. H. Ishiura, W. Sako, and M. Yoshida The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement Am. J. Hum. Genet. 91 2012 320 329
17. Y. Takahashi, Y. Fukuda, and J. Yoshimura ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19 Am. J. Hum. Genet. 93 2013 900 905
18. T.A. Manolio Genomewide association studies and assessment of the risk of disease N. Engl. J. Med. 363 2010 166 176
19. D.E. Reich, and E.S. Lander On the allelic spectrum of human disease Trends Genet. 17 2001 502 510
20. N. Risch, and K. Merikangas The future of genetic studies of complex human diseases Science 273 1996 1516 1517
21. N.J. Risch Searching for genetic determinants in the new millennium Nature 405 2000 847 856
22. T.A. Manolio, F.S. Collins, and N.J. Cox Finding the missing heritability of complex diseases Nature 461 2009 747 753
23. M.F. Keller, M. Saad, and J. Bras Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease Hum. Mol. Genet. 21 2012 4996 5009
24. T.H. Hamza, and H. Payami The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors J. Hum. Genet. 55 2010 241 243
25. K. Wirdefeldt, M. Gatz, and C.A. Reynolds Heritability of Parkinson disease in Swedish twins: a longitudinal study Neurobiol. Aging 32 2011 1923 (e1921-1928)
26. A. Goate, M.C. Chartier-Harlin, and M. Mullan Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706
27. S. Naruse, S. Igarashi, and H. Kobayashi Mis-sense mutation Val-Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease Lancet 337 1991 978 979
28. R. Sherrington, E.I. Rogaev, and Y. Liang Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
29. E. Levy-Lahad, W. Wasco, and P. Poorkaj Candidate gene for the chromosome 1 familial Alzheimer's disease locus Science 269 1995 973 977
30. M. Cruts, and C. Van Broeckhoven Presenilin mutations in Alzheimer's disease Hum. Mutat. 11 1998 183 190
31. C. Hirst, I.M. Yee, and A.D. Sadovnick Familial risks for Alzheimer disease from a population-based series Genet. Epidemiol. 11 1994 365 374
32. G. Devi, R. Ottman, and M.X. Tang Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan Arch Neurol. 57 2000 72 77
33. N.L. Pedersen, M. Gatz, and S. Berg How heritable is Alzheimer's disease late in life? Findings from Swedish twins Ann. Neurol. 55 2004 180 185
34. S. Sadigh-Eteghad, M. Talebi, and M. Farhoudi Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer's disease. A meta-analysis Neurosciences (Riyadh) 17 2012 321 326
35. M.A. Pericak-Vance, J.L. Bebout, and P.C. Gaskell Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage Am. J. Hum. Genet. 48 1991 1034 1050
36. E.H. Corder, A.M. Saunders, and W.J. Strittmatter Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
37. W.J. Strittmatter, A.M. Saunders, and D. Schmechel Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 90 1993 1977 1981
38. K. Okuizumi, O. Onodera, and H. Tanaka ApoE-epsilon 4 and early-onset Alzheimer's Nat. Genet. 7 1994 10 11
39. A. Alpérovitch, A. Boland, and M. Delépoine Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease Nat. Genet. 45 2013 1452 1458
40. L. Bertram, C.M. Lill, and R.E. Tanzi The genetics of Alzheimer disease: back to the future Neuron 68 2010 270 281
41. C. Cruchaga, C.M. Karch, and S.C. Jin Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease Nature 505 2014 550 554
42. L.M. de Lau, and M.M. Breteler Epidemiology of Parkinson's disease Lancet Neurol. 5 2006 525 535
43. M.H. Polymeropoulos, C. Lavedan, and E. Leroy Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
44. A.B. Singleton, M. Farrer, and J. Johnson Alpha-Synuclein locus triplication causes Parkinson's disease Science 302 2003 841
45. A. Zimprich, S. Biskup, and P. Leitner Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607
46. C. Paisán-Ruíz, S. Jain, and E.W. Evans Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease Neuron 44 2004 595 600
47. M.C. Chartier-Harlin, J.C. Dachsel, and C. Vilariño-Güell Translation initiator EIF4G1 mutations in familial Parkinson disease Am. J. Hum. Genet. 89 2011 398 406
48. A. Zimprich, A. Benet-Pagès, and W. Struhal A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease Am. J. Hum. Genet. 89 2011 168 175
49. T. Kitada, S. Asakawa, and N. Hattori Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608
50. E.M. Valente, P.M. Abou-Sleiman, and V. Caputo Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
51. V. Bonifati, P. Rizzu, and M.J. van Baren Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 299 2003 256 259
52. C. Paisan-Ruiz, K.P. Bhatia, and A. Li Characterization of PLA2G6 as a locus for dystonia-parkinsonism Ann. Neurol. 65 2009 19 23
53. S. Shojaee, F. Sina, and S.S. Banihosseini Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays Am. J. Hum. Genet. 82 2008 1375 1384
54. M.R. Cookson Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways Cold Spring Harb. Perspect. Med. 2 2012 a009415
55. I. Celardo, L.M. Martins, and S. Gandhi Unravelling mitochondrial pathways to Parkinson's disease Br. J. Pharmacol. 2013
56. M.A. Nalls, V. Plagnol, and D.G. Hernandez Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies Lancet 377 2011 641 649
57. M. Sharma, J.P. Ioannidis, and J.O. Aasly Large-scale replication and heterogeneity in Parkinson disease genetic loci Neurology 79 2012 659 667
58. C.M. Lill, J.T. Roehr, and M.B. McQueen Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database PLoS Genet. 8 2012 e1002548
59. W. Satake, Y. Nakabayashi, and I. Mizuta Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease Nat. Genet. 41 2009 1303 1307
60. J. Simón-Sánchez, C. Schulte, and J.M. Bras Genome-wide association study reveals genetic risk underlying Parkinson's disease Nat. Genet. 41 2009 1308 1312
61. O. Goker-Alpan, R. Schiffmann, and M.E. LaMarca Parkinsonism among Gaucher disease carriers J. Med. Genet. 41 2004 937 940
62. E. Sidransky, M.A. Nalls, and J.O. Aasly Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease N. Engl. J. Med. 361 2009 1651 1661
63. A. Zimran, T. Gelbart, and B. Westwood High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews Am. J. Hum. Genet. 49 1991 855 859
64. J. Aharon-Peretz, H. Rosenbaum, and R. Gershoni-Baruch Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews N. Engl. J. Med. 351 2004 1972 1977
65. J. Mitsui, I. Mizuta, and A. Toyoda Mutations for Gaucher disease confer high susceptibility to Parkinson disease Arch. Neurol. 66 2009 571 576
66. M. Anheim, A. Elbaz, and S. Lesage Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers Neurology 78 2012 417 420
67. J.G. Graham, and D.R. Oppenheimer Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy J. Neurol. Neurosurg. Psychiatry 32 1969 28 34
68. M.I. Papp, J.E. Kahn, and P.L. Lantos Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) J. Neurol. Sci. 94 1989 79 100
69. P.H. Tu, J.E. Galvin, and M. Baba Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein Ann. Neurol. 44 1998 415 422
70. K. Wakabayashi, M. Yoshimoto, and S. Tsuji Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy Neurosci. Lett. 249 1998 180 182
71. K. Arima, K. Ueda, and N. Sunohara NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy Acta Neuropathol. 96 1998 439 444
72. M.G. Spillantini, R.A. Crowther, and R. Jakes Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies Neurosci. Lett. 251 1998 205 208
73. Y. Nakazato, H. Yamazaki, and J. Hirato Oligodendroglial microtubular tangles in olivopontocerebellar atrophy J. Neuropathol. Exp. Neurol. 49 1990 521 530
74. E. Jaros, and D.J. Burn The pathogenesis of multiple system atrophy: past, present, and future Mov. Disord. 15 2000 784 788
75. S. Gilman, G.K. Wenning, and P.A. Low Second consensus statement on the diagnosis of multiple system atrophy Neurology 71 2008 670 676
76. H. Watanabe, Y. Saito, and S. Terao Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients Brain 125 2002 1070 1083
77. S. Tsuji, O. Onodera, and J. Goto Sporadic ataxias in Japan - a population-based epidemiological study Cerebellum 7 2008 189 197
78. F. Geser, K. Seppi, and M. Stampfer-Kountchev The European multiple system atrophy-study group (EMSA-SG) J. Neural Transm. 112 2005 1677 1686
79. S. May, S. Gilman, and B.B. Sowell Potential outcome measures and trial design issues for multiple system atrophy Mov. Disord. 22 2007 2371 2377
80. G.K. Wenning, S. Wagner, and S. Daniel Multiple system atrophy: sporadic or familial? Lancet 342 1993 681
81. K. Hara, Y. Momose, and S. Tokiguchi Multiplex families with multiple system atrophy Arch. Neurol. 64 2007 545 551
82. U. Wüllner, I. Schmitt, and M. Kammal Definite multiple system atrophy in a German family J. Neurol. Neurosurg. Psychiatry 80 2009 449 450
83. A.D. Hohler, and V.J. Singh Probable hereditary multiple system atrophy-autonomic (MSA-A) in a family in the United States J. Clin. Neurosci. 19 2012 479 480
84. S.W. Scholz, H. Houlden, and C. Schulte SNCA variants are associated with increased risk for multiple system atrophy Ann. Neurol. 65 2009 610 614
85. A. Al-Chalabi, A. Durr, and N.W. Wood Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy PLoS One 4 2009 e7114
86. O.A. Ross, C. Vilariño-Güell, and Z.K. Wszolek Reply to: SNCA variants are associated with increased risk of multiple system atrophy Ann. Neurol. 67 2010 414 415
87. J.Y. Yun, W.W. Lee, and J.Y. Lee SNCA variants and multiple system atrophy Ann. Neurol. 67 2010 554 555
88. T. Ozawa, H. Takano, and O. Onodera No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy Neurosci. Lett. 270 1999 110 112
89. H. Sasaki, M. Emi, and H. Iijima Copy number loss of (Src homology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy Mol. Brain 4 2011 24
90. The Multiple-System Atrophy Research Collaboration Mutations in COQ2 in familial and sporadic multiple-system atrophy N. Engl. J. Med. 369 2013 233 244
91. V. Emmanuele, L.C. López, and A. Berardo Heterogeneity of coenzyme Q10 deficiency: patient study and literature review Arch. Neurol. 69 2012 978 983
92. D.B. Goldstein, A. Allen, and J. Keebler Sequencing studies in human genetics: design and interpretation Nat. Rev. Genet. 14 2013 460 470
93. J.N. Foo, J.J. Liu, and E.K. Tan Whole-genome and whole-exome sequencing in neurological diseases Nat. Rev. Neurol. 8 2012 508 517
94. W. Fu, T.D. O'Connor, and G. Jun Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants Nature 493 2013 216 220